Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma.

ABSTRACT:

SUBMITTER: Jaeger U 

PROVIDER: S-EPMC9631665 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature